Awards & Other Accomplishments Archives | Page 12 of 37 | Be Korea-savvy

Archive by category Awards & Other Accomplishments

AiViva Biopharma Completes Enrollment in a Phase 1 Clinical Trial of AIV007 for Age-Related Macular Degeneration and Diabetic Macular Edema

AiViva Biopharma Completes Enrollment in a Phase 1 Clinical Trial of AIV007 for Age-Related Macular Degeneration and Diabetic Macular Edema

Novel JEL™ Technology for Periocular Administration COSTA MESA, Calif., Aug. 23, 2024 (Korea Bizwire) – AiViva Biopharma Inc., a clinical-stage biotechnology company, announced that it has fully enrolled and completed dosing the last patient in a Phase 1 trial with wet age-related macular degeneration (wAMD), and/or diabetic macular edema (DME). “We have achieved a major [...]

Brains Bioceutical Set to Achieve One of the World’s First CEP for Cannabidiol Certification with the European Directorate for the Quality of Medicines & Healthcare

Brains Bioceutical Set to Achieve One of the World’s First CEP for Cannabidiol Certification with the European Directorate for the Quality of Medicines & Healthcare

Advancing Pharmaceutical Innovation: Brains Bioceutical’s CEP Certification will Streamline Cannabinoid Drug Development, Inspired by Jazz Pharmaceuticals’ CBD-Based Epilepsy Drug and 2024 $1.4 Billion Revenue Projection SANDWICH, United Kingdom, Aug. 22, 2024 (Korea Bizwire) – Brains Bioceutical Corp. (BBC) has achieved a groundbreaking milestone by submitting one of the world’s first CEP (Certification of Suitability) application [...]

Christie’s International Real Estate Enters Singapore as Luxury Brand Continues Expansion in Southeast Asia

Christie’s International Real Estate Enters Singapore as Luxury Brand Continues Expansion in Southeast Asia

Christie’s International Real Estate Singapore looks to capitalize on Singapore’s luxury real estate market SINGAPORE and CHICAGO, Aug. 21, 2024 (Korea Bizwire) – Christie’s International Real Estate, a global leader in luxury real estate, has officially launched in Singapore, marking a significant milestone in its Southeast Asia expansion strategy.  Operating from a newly refurbished historic shophouse [...]

VistaJet Celebrates 20 Years of Making Dreams with more Private World Voyages

VistaJet Celebrates 20 Years of Making Dreams with more Private World Voyages

London, August 21, 2024: As VistaJet marks two decades as the global leader in private aviation, the company celebrates their rich history and their commitment to discovering all the planet can offer with its ever-expanding Private World program. Private World is a gift for all VistaJet Members, to fully immerse in the iconic silver and red legacy. Luxury [...]

Carilion Clinic Further Expands Quality Cardiac Care Access with Latest Philips Innovations at New Regional Cardiovascular Institute in Virginia, US

Carilion Clinic Further Expands Quality Cardiac Care Access with Latest Philips Innovations at New Regional Cardiovascular Institute in Virginia, US

August 20, 2024 Integrated Philips cardiovascular solutions enhance the patient & staff experience with reduced X-ray dose & procedure time for more time with patients and to help improve outcomes New facility will have 11 specialized Philips interventional suites, allowing physicians to treat patients with complex cardiovascular conditions closer to home Amsterdam, The Netherlands and [...]

SolarMax Technology Expands US Footprint with New Commercial Solar Project in California

SolarMax Technology Expands US Footprint with New Commercial Solar Project in California

RIVERSIDE, Calif., Aug. 15, 2024 (Korea Bizwire) – SolarMax Technology, Inc. (Nasdaq SMXT) (“SolarMax” or the “Company”), an integrated solar energy company, signed a non-binding term sheet for a significant new commercial solar project in California. The project, a major mall in the San Jose area, represents another step forward in SolarMax’ ongoing strategy to [...]

Nong Yao C First Oil

Nong Yao C First Oil

SINGAPORE, Aug. 15, 2024 (Korea Bizwire) – Valeura Energy Inc. (TSX:VLE, OTCQX:VLERF) (“Valeura” or the “Company”) is pleased to announce first oil production from its Nong Yao C development, in Licence G11/48 (90% operated working interest), offshore Gulf of Thailand.  The first three of the seven Nong Yao C development wells were opened up for [...]

Stevie® Awards Announce Winners in The 21st Annual International Business Awards® from Across the Globe

Stevie® Awards Announce Winners in The 21st Annual International Business Awards® from Across the Globe

Selected From More Than 3,600 Nominations, Representing 62 Nations and Territories, by More Than 300 Judges FAIRFAX, Va., Aug. 14, 2024 (Korea Bizwire) – High-achieving organizations and executives around the world have been recognized as Gold, Silver, and Bronze Stevie® Award winners in The 21st Annual International Business Awards®, the world’s only international, all-encompassing business awards [...]

Junshi Biosciences Announces Acceptance of Supplemental New Drug Application for Toripalimab as First-Line Treatment of Unresectable/Metastatic Melanoma

Junshi Biosciences Announces Acceptance of Supplemental New Drug Application for Toripalimab as First-Line Treatment of Unresectable/Metastatic Melanoma

SHANGHAI, Aug. 12, 2024 (Korea Bizwire) – Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the National Medical Products Administration (NMPA) has accepted for review the supplemental new drug application (sNDA) for toripalimab (trade name: [...]

Sandoz Receives FDA Approval for Enzeevu™ (aflibercept-abzv), Further Strengthening US Biosimilar Position

Sandoz Receives FDA Approval for Enzeevu™ (aflibercept-abzv), Further Strengthening US Biosimilar Position

Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules Enzeevu™ (aflibercept-abzv) approved to treat neovascular age-related macular degeneration Further enhances leading US ophthalmology portfolio and increases access for patients Expected to be key biosimilar growth driver in US Basel, August 12, 2024 – Sandoz (SIX:SDZ/OTCQX:SDZNY), the global leader in generic and biosimilar medicines, [...]